ArticleFrontiers in oncology2025

Metabolome profiling by untargeted metabolomics and biomarker panel selection using machine-learning for patients in different stages of peripheral neuropathy induced by oxaliplatin.

Yu-Jiao Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.